FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Issues Guidance on Malaria Drug Development

[ Price : $8.95]

FDA posts a draft guidance entitled Malaria: Developing Drugs for Treatment that outlines key considerations for companies develop...

Lexicon Submits New Data to FDA on Zynquista

[ Price : $8.95]

Lexicon Pharmaceuticals says FDA is requiring additional time to review its new clinical data submitted earlier this month in an e...

Priority Review for Rare Vision-Loss Disorder Drug

[ Price : $8.95]

FDA accepts for priority review a Chiesi NDA for idebenone and its use in treating Leber hereditary optic neuropathy.

Device Inspections Show Tougher Enforcement: Law Firm

[ Price : $8.95]

FDA escalates medical device oversight this year, issuing more Warning Letters and relying on artificial intelligence to zero-in o...

Rep. Pallone Blasts RFK Jr. Over Vaccine Changes

[ Price : $8.95]

Rep. Frank Pallone Jr. (D-NJ) sharply criticizes Health and Human Services Secretary Robert F. Kennedy Jr., accusing him of underm...

FDA OKs Medtronics Altaviva Implant for Incontinence

[ Price : $8.95]

FDA approves Medtronics Altaviva implantable tibial neuromodulation device for treating urge urinary incontinence.

10/9 Vaccines Panel to Recommend Flu Strain Selection

[ Price : $8.95]

FDA schedules a 10/9 Vaccines and Related Biological Products Advisory Committee meeting to make recommendations on the strain sel...

Mercks Keytruda Qlex Approved by FDA

[ Price : $8.95]

FDA approves Mercks pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for subcutaneous injection for adult and pediatr...

FDA Reverts Lab Test Reg. After Court Ruling

[ Price : $8.95]

FDA publishes a final rule rolling back a 2024 regulation that expanded the agencys authority over laboratory-developed tests.

FDA OKs Expanded Labeling for Asthma Drug

[ Price : $8.95]

FDA approves an AstraZeneca supplemental NDA for Airsupra (albuterol/budesonide) to expand the drugs labeling to reflect a 46% red...